Market revenue in 2023 | USD 432.9 million |
Market revenue in 2030 | USD 707.5 million |
Growth rate | 7.3% (CAGR from 2023 to 2030) |
Largest segment | Outpatient facilities |
Fastest growing segment | Home Care |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Hospitals, Outpatient Facilities, Home Care, Research & Manufacturing |
Key market players worldwide | BD, Danaher Corp, Koninklijke Philips NV, Qiagen NV, Thermo Fisher Scientific Inc, Myriad Genetics Inc, Argon Medical Devices, Roche Holding AG ADR, Hologic Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to breast cancer diagnostics market will help companies and investors design strategic landscapes.
Outpatient facilities was the largest segment with a revenue share of 63.94% in 2023. Horizon Databook has segmented the Middle East & Africa breast cancer diagnostics market based on hospitals, outpatient facilities, home care, research & manufacturing covering the revenue growth of each sub-segment from 2018 to 2030.
Rising demand for effective and cost-efficient breast cancer diagnostics is one of the major factors contributing to the growth of the breast cancer diagnostics market in the MEA region. Factors such as increase in the need for improved healthcare infrastructure and high burden of cancer are expected to boost the demand for advanced diagnostic & predictive strategies.
Increasing awareness pertaining to breast cancer is expected to boost market growth. According to the UAE health guidelines, all women aged 30 to 40 should get a clinical breast examination done once in every 3 years and women over 20 years should be breast aware. Due to vast financial resources and adequate government funding in countries like UAE, breast cancer diagnostics market is advancing steadily.
The country’s Ministry of Health has collaborated with Abu Dhabi and Dubai Health Authority in the past different awareness campaigns for diseases such as cancer and infectious diseases. These initiatives are among the reasons for the significant growth of breast cancer diagnostics market.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa breast cancer diagnostics market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa breast cancer diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account